Polyalanine and polyserine frameshift products in Huntington's disease

Journal of Medical Genetics

Volumn 43, Issue 11, 2006, Pages 893-896

  Davies, J E ^a   Rubinsztein, D C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE DERIVATIVE; POLYALANINE; POLYSERINE; SERINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; CONTROLLED STUDY; FRAMESHIFT MUTATION; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BRAIN; FRAMESHIFT MUTATION; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MICE; PEPTIDES; TRINUCLEOTIDE REPEAT EXPANSION;

MUS MUSCULUS;

EID: 33751244242     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.044222     Document Type: Article

References (14)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
2. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-3.
3. Gusella JF, MacDonald ME. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 2000;1:109-15.
4. Brown LY, Brown SA. Alanine tracts: the expanding story of human illness and trinucleotide repeats. Trends Genet 2004;20:51-8.
5. Davies JE, Berger Z, Rubinsztein DC. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder. Int J Biochem Cell Biol 2006.
6. Uyama E, Tsukahara T, Goto K, et al. Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy. Muscle Nerve 2000;23:1549-54.
7. Tome FM, Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol (Berl) 1980;49:85-7.
8. Gaspar C, Jannatipour M, Dion P, et al. CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation. Hum Mol Genet 2000;9:1957-66.
9. Toulouse A, Au-Yeung F, Gaspar C, et al. Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts. Hum Mol Genet 2005;14:2649-60.
10. Berger Z, Davies JE, Luo S, et al. Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion. Hum Mol Genet 2006;15:453-65.
11. Schilling G, Becher MW, Sharp AH, et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 1999;8:397-407.
12. Ravikumar B, Vacher C, Berger Z, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004;36:585-95.
13. Wyttenbach A, Swartz J, Kita H, et al. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet 2001;10:1829-45.
14. Li SH, Cheng AL, Zhou H, et al. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 2002;22:1277-87.